EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HE4 immunohistochemical expression in serous carcinomas of the ovary and uterus: A pathological guide to primary site determination

Sara Mohamad Abou-Fandoud, Mai Omar Elfarouk Elsherbeiny, Shaimaa Mohamed Abdelsalam

Egyptian Journal of Pathology · 2025-07 · 45 (2) · 90-95

DOI: 10.4103/egjp.egjp_12_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Egyptian Journal of Pathology, online erschienen am 11.03.2026. Verfasst von Sara Mohamad Abou-Fandoud und 2 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Uterine serous carcinoma and high-grade serous ovarian cancer exhibit identical morphological characteristics, irrespective of their site of origin, necessitating an immunohistochemical marker to ascertain tumor origin. Human epididymis protein (HE4) is variably expressed in endometrial and ovarian carcinomas. This study seeks to evaluate the significance of HE4 in identifying the anatomical origin of malignancies by contrasting its expression levels between the two tumor types.

Results

In 14 out of 20 cases of uterine serous carcinoma and in 22 out of 30 cases of ovarian serous carcinoma, HE4 tissue immunoexpression was found. The frequency of HE4 immunostaining expression was insignificant between the two groups (uterine and ovarian serous carcinoma) ( P =0.956). HE4 expression and tumor staging in the studied cases showed a significant statistical relation.

Conclusion

These data indicate no significant relation between HE4 expression and tumor origin, which makes the value of HE4 in recognizing tumor origin doubtful. Based on long-term follow-up, larger studies including a larger number of patients are required.

Zitieren

APA

Abou-Fandoud, S. M., Elsherbeiny, M. O. E., & Abdelsalam, S. M. (2025). HE4 immunohistochemical expression in serous carcinomas of the ovary and uterus: A pathological guide to primary site determination. Egyptian Journal of Pathology, 45(2), 90-95. https://doi.org/10.4103/egjp.egjp_12_25

Vancouver

Abou-Fandoud SM, Elsherbeiny MOE, Abdelsalam SM. HE4 immunohistochemical expression in serous carcinomas of the ovary and uterus: A pathological guide to primary site determination. Egyptian Journal of Pathology. 2025;45(2):90-95. doi:10.4103/egjp.egjp_12_25

BibTeX
@article{AbouFandoud2025,
  author = {Abou-Fandoud, Sara Mohamad and Elsherbeiny, Mai Omar Elfarouk and Abdelsalam, Shaimaa Mohamed},
  title = {HE4 immunohistochemical expression in serous carcinomas of the ovary and uterus: A pathological guide to primary site determination},
  journal = {Egyptian Journal of Pathology},
  year = {2025},
  volume = {45},
  number = {2},
  pages = {90--95},
  doi = {10.4103/egjp.egjp_12_25}
}
Kostenlos starten →